Structure of a trial. by Marcel F. Hinss (14675457)

Subjects:

Graph of surface roughness values of specimens after testing with different particle sizes at a concentration of 0.4 mg/mL (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Subjects:

Graph of surface roughness values of specimens after testing with different particle sizes at a concentration of 4 mg/mL (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Subjects:

Evolution of sportspersonship in the different categories of the FRM schools and the association football clubs. by Gema Ortega Vila (19870900)

Subjects:

RT (in ms, bars) and ACC (in %, line) for the effect of congruency task convergence, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

Particle size distribution chart of 10-micron iron oxide particles. by Yang Li (7082)

Subjects:

Effect of the type of switch trial on performance. by Marcel F. Hinss (14675457)

Subjects:

Evolution of personal factors in the different categories in the FRM social sports schools and in the association football clubs. by Gema Ortega Vila (19870900)

Subjects:

Graph of temperature rise variation for test groups with different particle sizes at two concentrations. by Yang Li (7082)

Subjects:

Parameter diagram for pit features on the specimen surface (a) Volume (b) Surface Area (c) Depth (d) Cross-sectional area. by Yang Li (7082)

Subjects:

Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

Subjects:

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Subjects:

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

Subjects:

Hemodynamic effects of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

Subjects:

<i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats. by Tobias G. Schips (21799838)

Subjects:

Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

Subjects:

Characterization of safety pharmacology of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

Tunel detection of myocardial apoptosis. by Qingqing Hao (5464070)

Subjects: